After a Type 2 Diabetes Diagnosis, Does Improving Diet Quality Affect Longevity?
A new long-term study offers an encouraging message for people living with type 2 diabetes: people whose eating patterns scored higher for quality after diagnosis, or improved more over time, had lower observed mortality during follow-up. The study does not show that a particular diet caused people to live longer. It does not prove that […]
GLP-1 Medicines in Type 2 Diabetes: What a New Consensus Supports—and What They Do Not Replace
GLP-1 receptor agonists are often discussed as if they are a single answer to a very complicated condition. In reality, they are one category of prescription medicines that may help selected people with type 2 diabetes, obesity, chronic kidney disease, or cardiovascular risk. The decision to use one depends on the person’s medical history, treatment […]
Sleep and Type 2 Diabetes: Why Sleep Quality Belongs in a Whole-Person Care Plan
When people talk about managing type 2 diabetes, the conversation usually turns to food, medications, physical activity, or glucose monitoring. Sleep is often left out—despite the fact that poor sleep can affect energy, mood, appetite, activity, and the ability to follow through on every other part of a care plan. A new study adds to […]
The Muscle Molecule Released With Exercise: What L-BAIBA Research Means for Type 2 Diabetes Care
When people hear that exercise is useful for type 2 diabetes, they may think first about calories, weight loss, or “earning” food. That framing misses much of the biology—and it can make movement feel like a punishment. Muscles are active metabolic organs. When they contract, they use glucose, communicate with other tissues, adapt to training, […]
Food Is Medicine Works Best When It Is Built Into Care—not Added as an Afterthought
“Food is medicine” is an appealing phrase because it names something many people living with type 2 diabetes already know: food choices are not a side note. They affect energy, glucose patterns, blood pressure, lipids, sleep, and the routines that make treatment sustainable. But the phrase can also become vague. Telling someone to “eat better” […]
A GLP-1 Prescription Is Not a Complete Care Plan: What Responsible Evaluation and Follow-Up Look Like
GLP-1 medicines have become a major part of conversations about weight, blood sugar, and metabolic health. That visibility has created opportunity: some people who once felt shut out of care are now asking better questions about diabetes, obesity, and long-term risk. It has also created a problem. A medication can be presented online as if […]
GLP-1s After 60: Why Medication Decisions Must Protect Strength, Function, and Independence
Source note: This article was prompted by reporting on GLP-1 medicines and aging, plus a commentary on the history of weight-loss culture. The question is not simply “Will it cause weight loss?” GLP-1 receptor agonists have changed the conversation around obesity and type 2 diabetes. These medicines can improve glucose control in people with type […]
Type 2 Diabetes Remission Is a Clinical Goal—Not a Marketing Promise
A more useful conversation than “cure” versus “control” People living with type 2 diabetes deserve more than a conversation limited to “manage this forever” or, at the other extreme, “reverse it quickly.” A better conversation is about remission: a measurable clinical outcome that may be achievable for some people through an individualized, sustained approach to […]